AMMOS: A Tool for Optimizing Molecular Structures in Drug Discovery
Author Information
Author(s): Tania Pencheva, David Lagorce, Ilza Pajeva, Bruno O. Villoutreix, Maria A. Miteva
Primary Institution: INSERM U648, Bioinformatics-MTI University Paris Diderot
Hypothesis
Can the AMMOS program improve the efficiency of virtual ligand screening by optimizing molecular structures?
Conclusion
The AMMOS program effectively enhances the structural refinement of compounds and improves the enrichment of active compounds in virtual ligand screening.
Supporting Evidence
- AMMOS improved the enrichment of active compounds found in the top 3% to 5% of the entire compound collection.
- The program was validated on two protein targets, estrogen receptor and neuraminidase, showing effective performance.
- AMMOS can minimize a large number of ligands efficiently, making it suitable for high-throughput applications.
Takeaway
AMMOS is a computer program that helps make drug discovery faster by improving how we find and optimize potential new medicines.
Methodology
AMMOS uses molecular mechanics to refine the 3D structures of small molecules and protein-ligand complexes through energy minimization.
Limitations
AMMOS does not account for solvation effects and may not optimize structures with severe internal clashes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website